Åm, M. K. http://orcid.org/0000-0001-8245-6893
Teigen, I. A.
Riaz, M.
Fougner, A. L.
Christiansen, S. C.
Carlsen, S. M.
Funding for this research was provided by:
Norges Forskningsråd (248872, 294828)
Helse Midt-Norge (2020/39645)
NTNU Norwegian University of Science and Technology
Article History
Received: 28 April 2023
Accepted: 1 September 2023
First Online: 15 September 2023
Declarations
:
: The Norwegian University of Science and Technology (NTNU), the university where the several of the author reside, has a patent filed related to the use of micro-boluses of glucagon. The authors SMC, SCC, and ALF are some of the inventors. The remaining authors have no conflicts of interest to declare.
: The research group Artificial Pancreas Trondheim (APT) have consulted with the user board consisting of people with DM1. The user board has guided and provided feedback to the research conducted by APT.
: For this review, no informed consent is required.